Strategically Comprehensive Immunotherapy Employing Modified Antibody Targeting NY-ESO-1 for Multiple Myeloma

被引：0
|
作者：
Maruta, Masaki [1 ]
Tanimoto, Kazushi [1 ]
Azuma, Taichi [1 ]
Fujiwara, Hiroshi [1 ]
Yasukawa, Masaki [1 ]
机构：
[1] Ehime Univ, Sch Med, Dept Int Med 1, Matsuyama, Ehime, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Immune cell therapy; Multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2374
引用
收藏
页码：757 / 757
页数：1
相关论文
共 50 条
  • [1] NY-ESO-1 immunotherapy for multiple myeloma
    Szmania, Susann
    Tricot, Guido
    van Rhee, Frits
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2037 - 2048
  • [2] DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TARGETING NY-ESO-1
    Sun, Matthew
    Orpilla, Joey
    Contreras, Erick
    Imbroane, Marisa
    Treger, Janet
    Wang, Anthony
    Ko, MyungJun
    Vitte, Jeremie
    Giovannini, Marco
    Liau, Linda M.
    Prins, Robert
    Everson, Richard G.
    NEURO-ONCOLOGY, 2022, 24 : 229 - 229
  • [3] ADOPTIVE TRANSFER IMMUNOTHERAPY TARGETING NY-ESO-1 FOR TREATMENT OF GLIOBLASTOMA
    Everson, Richard G.
    Lisiero, Dominique N.
    Soto, Horacio
    Liau, Linda M.
    Prins, Robert M.
    NEURO-ONCOLOGY, 2012, 14 : 41 - 42
  • [4] Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma
    Everson, Richard G.
    Antonios, Joseph P.
    Lisiero, Dominique N.
    Soto, Horacio
    Scharnweber, Rudi
    Garrett, Matthew C.
    Yong, William H.
    Li, Ning
    Li, Gang
    Kruse, Carol A.
    Liau, Linda M.
    Prins, Robert M.
    NEURO-ONCOLOGY, 2016, 18 (03) : 368 - 378
  • [5] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [6] Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
    Kawabata, Ryohei
    Wada, Hisashi
    Isobe, Midori
    Saika, Takashi
    Sato, Shuichiro
    Uenaka, Akiko
    Miyata, Hiroshi
    Yasud, Takushi
    Doki, Yuichiro
    Noguchi, Yuji
    Kumon, Hiromi
    Tsuji, Kazuhide
    Iwatsuki, Keiji
    Shiku, Hiroshi
    Ritter, Gerd
    Murphy, Roger
    Hoffman, Eric
    Old, Lloyd J.
    Monden, Morito
    Nakayama, Eiichi
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) : 2178 - 2184
  • [7] NY-ESO-1 antigen: A promising frontier in cancer immunotherapy
    Alsalloum, Alaa
    Shevchenko, Julia A.
    Sennikov, Sergey
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (09):
  • [8] Prognostic significance of NY-ESO-1 gene expression in multiple myeloma patients.
    Usui, E
    Nishii, K
    Lorenzo, F
    Katayama, N
    Shiku, H
    BLOOD, 2003, 102 (11) : 368B - 368B
  • [9] NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Roelands, Jessica
    Hendrickx, Wouter
    Dermime, Said
    Bedognetti, Davide
    Decock, Julie
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [10] Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy
    Hamai, Ahmed
    Duperrier-Amouriaux, Karine
    Pignon, Pascale
    Raimbaud, Isabelle
    Memeo, Lorenzo
    Colarossi, Cristina
    Canzonieri, Vincenzo
    Perin, Tiziana
    Classe, Jean-Marc
    Campone, Mario
    Jezequel, Pascal
    Campion, Loic
    Ayyoub, Maha
    Valmori, Danila
    PLOS ONE, 2011, 6 (06):
12345